SPATS2L and acute myeloid leukemia: Further multivariate analysis demonstrated high SPATS2L expression in AML was an independent poor prognostic marker for OS (P = 0.025, HR = 1.631), EFS (P = 0.0001, HR = 1.894), and especially for RFS (P < 0.0001, HR = 3.345) (Table 2).